PT1129721E - Utilizacao de dominios isolados de colagenio tipo iv para modificar interaccoes entre celulas e entre tecidos - Google Patents

Utilizacao de dominios isolados de colagenio tipo iv para modificar interaccoes entre celulas e entre tecidos

Info

Publication number
PT1129721E
PT1129721E PT01108470T PT01108470T PT1129721E PT 1129721 E PT1129721 E PT 1129721E PT 01108470 T PT01108470 T PT 01108470T PT 01108470 T PT01108470 T PT 01108470T PT 1129721 E PT1129721 E PT 1129721E
Authority
PT
Portugal
Prior art keywords
cell
mesoglea
collagenal
domains
cells
Prior art date
Application number
PT01108470T
Other languages
English (en)
Inventor
Billy G Hudson
Michael P Sarras Jr
Original Assignee
Univ Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas Medical Center filed Critical Univ Kansas Medical Center
Publication of PT1129721E publication Critical patent/PT1129721E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
PT01108470T 1994-06-30 1995-06-30 Utilizacao de dominios isolados de colagenio tipo iv para modificar interaccoes entre celulas e entre tecidos PT1129721E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/268,969 US5567609A (en) 1994-06-30 1994-06-30 Use of isolated domains of type IV collagen to modify cell and tissue interactions

Publications (1)

Publication Number Publication Date
PT1129721E true PT1129721E (pt) 2004-07-30

Family

ID=23025295

Family Applications (2)

Application Number Title Priority Date Filing Date
PT95926149T PT767676E (pt) 1994-06-30 1995-06-30 Utilizacao de dominios isolados de colagenio do tipo iv para modificar as interaccoes de celulas e tecidos
PT01108470T PT1129721E (pt) 1994-06-30 1995-06-30 Utilizacao de dominios isolados de colagenio tipo iv para modificar interaccoes entre celulas e entre tecidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT95926149T PT767676E (pt) 1994-06-30 1995-06-30 Utilizacao de dominios isolados de colagenio do tipo iv para modificar as interaccoes de celulas e tecidos

Country Status (9)

Country Link
US (7) US5567609A (pt)
EP (2) EP0767676B1 (pt)
AT (2) ATE209043T1 (pt)
AU (1) AU3000895A (pt)
DE (2) DE69524094T2 (pt)
DK (2) DK0767676T3 (pt)
ES (2) ES2217050T3 (pt)
PT (2) PT767676E (pt)
WO (1) WO1996000582A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567609A (en) * 1994-06-30 1996-10-22 University Of Kansas Medical Center Use of isolated domains of type IV collagen to modify cell and tissue interactions
US6440729B1 (en) * 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen
US6358735B1 (en) 1995-06-30 2002-03-19 University Of Kansas Medical Center Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen
EP0878480A1 (en) 1997-05-14 1998-11-18 H.W. Prof. Dr. Müller A method for the improvement of neuronal regeneration
JP2002509895A (ja) * 1998-03-27 2002-04-02 ユニヴァースティ オブ カンザス メディカル センター 細胞および組織相互作用を修飾するためのｉｖ型コラーゲンの単離ドメインの使用
US6759047B1 (en) * 1998-06-17 2004-07-06 Beth Israel Deaconess Hospital Corp. Anti-angiogenic proteins and methods of use thereof
US6962974B1 (en) 1998-06-17 2005-11-08 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
US7387779B2 (en) * 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
JP2002517999A (ja) * 1998-06-17 2002-06-25 ベス イスラエル ディーコネス メディカル センター 抗血管形成タンパク質およびその使用方法
US20010018579A1 (en) 1998-12-18 2001-08-30 Walter Klemp Disposable absorbent garment having stretchable side waist regions
WO2000059532A1 (en) * 1999-04-01 2000-10-12 Biostratum, Inc. The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
US6893812B2 (en) * 2000-05-30 2005-05-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Three-dimensional ex vivo angiogenesis system
CN100447155C (zh) * 2001-05-23 2008-12-31 中国科学院上海上海生命科学研究院 具有抑制内皮细胞生长活性的重组人内皮生长抑制蛋白
AU2002329643B2 (en) * 2001-07-27 2006-11-16 University Of Kansas Medical Center Crystallized structure of type IV collagen NC1 domain hexamer
WO2004067762A2 (en) * 2003-01-27 2004-08-12 University Of Kansas Medical Center Crystallized structure of type iv collagen nc1 domain hexamer
CA2525369A1 (en) * 2003-05-09 2004-11-25 Frank J. Falco Methods for using gadolinium as a contrast media
US7432413B2 (en) 2005-12-16 2008-10-07 The Procter And Gamble Company Disposable absorbent article having side panels with structurally, functionally and visually different regions
US8664467B2 (en) 2006-03-31 2014-03-04 The Procter & Gamble Company Absorbent articles with feedback signal upon urination
US8491558B2 (en) 2006-03-31 2013-07-23 The Procter & Gamble Company Absorbent article with impregnated sensation material for toilet training
US8057450B2 (en) 2006-03-31 2011-11-15 The Procter & Gamble Company Absorbent article with sensation member
CA2671929C (en) 2006-12-04 2013-03-19 The Procter & Gamble Company Absorbent articles comprising graphics
WO2009153783A1 (en) * 2008-06-16 2009-12-23 Mor Research Applications Ltd. Monitoring skin metabolism products for evaluating burn injury
WO2013170433A1 (en) 2012-05-15 2013-11-21 The Procter & Gamble Company Absorbent article having characteristic waist end

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021404A (en) 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
US5567609A (en) * 1994-06-30 1996-10-22 University Of Kansas Medical Center Use of isolated domains of type IV collagen to modify cell and tissue interactions
US6440729B1 (en) * 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen

Also Published As

Publication number Publication date
US5691182A (en) 1997-11-25
DE69532835T2 (de) 2005-02-10
US6448222B1 (en) 2002-09-10
EP1129721B1 (en) 2004-03-31
DE69524094T2 (de) 2002-04-18
US6419924B1 (en) 2002-07-16
US5567609A (en) 1996-10-22
ATE262922T1 (de) 2004-04-15
DK0767676T3 (da) 2002-05-21
ES2164160T3 (es) 2002-02-16
US6384012B1 (en) 2002-05-07
ES2217050T3 (es) 2004-11-01
DE69532835D1 (de) 2004-05-06
US5856184A (en) 1999-01-05
US20030013194A1 (en) 2003-01-16
EP0767676A1 (en) 1997-04-16
EP1129721A3 (en) 2001-11-14
DE69524094D1 (de) 2002-01-03
WO1996000582A1 (en) 1996-01-11
ATE209043T1 (de) 2001-12-15
EP0767676B1 (en) 2001-11-21
PT767676E (pt) 2002-03-28
AU3000895A (en) 1996-01-25
DK1129721T3 (da) 2004-06-28
US6680293B2 (en) 2004-01-20
EP1129721A2 (en) 2001-09-05

Similar Documents

Publication Publication Date Title
PT1129721E (pt) Utilizacao de dominios isolados de colagenio tipo iv para modificar interaccoes entre celulas e entre tecidos
BR9900033A (pt) Pente de fixação ajustável.
BR9913586A (pt) Processos para controlar bioincrustação em um meio aquoso e para marcar biofilmes e agregados celulares em um meio aquoso
NO20003414D0 (no) Anvendelse av PPAR-<ypsilon> aktivatorer i dermatologi
BR0016520A (pt) Processo para a redução eletroquìmica de corantes reduzìveis
DE68905946D1 (de) Sulfoniumsalze und deren verwendung als photoinitiatoren.
MX147342A (es) Mejoras en aparato para la modificacion controlada del comportamiento de crecimiento reparacion y mantenimiento de tejido o celulas vivientes mediante informacion electrica codificada
BR9906540A (pt) Dispositivo portátil tento um mostrador compreendendo primeiro e segundo elementos,e, processo de economizar potência no mesmo
DE69404373T2 (de) Verwendung von 4-,4- und 5-, oder 4- und 6-substituierten Resorcin-Derivaten in kosmetischen oder dermopharmazeutischen Depigmentierungsmitteln
KR960008666B1 (en) Novel retinoid
EP0663596A3 (en) Electro-optical voltage probe with fiber-optic plate.
DK0984983T3 (da) Modulatorer af intracellulære inflammations-, celledöds- og celleoverlevelsesforlöb indeholdende et CARD- og et kinasedomæne
CN206907402U (zh) 一种移动式电力盘柜用自动警示牌
ES2119686B1 (es) Colorantes dispersos.
CN205900026U (zh) 旋转式文化传播装置
Council Report Highlights
El Meligy The establishment of an environmental non-governmental organization (ENGO) support center
ES150124U (es) Dispositivo suministrador de baberos.
Loper et al. Water Withdrawals and Consumption in Pennsylvania, 1984
Kia Evaluating regional policies in Canada; the case of Newfoundland.
Ramakrishnan Growing up with Sir Nevill Tiruppatur Ramakrishnan
BR7702389U (pt) Caixa de hidrÈmetro
BR7802313U (pt) Semáforo com cronÈmetro.
BR9104824A (pt) Cartilha da previdencia como usar o novo plano de beneficios da previdencia social
Pisani Espeland," The Struggle for Water: Politics, Rationality, and Identity in the American Southwest"(Book Review)